Literature DB >> 28802833

New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.

Charles N Serhan1, Nan Chiang2, Jesmond Dalli2.   

Abstract

While protective, the acute inflammatory response when uncontrolled can lead to further tissue damage and chronic inflammation that is now widely recognized to play important roles in many commonly occurring diseases, such as cardiovascular disease, neurodegenerative diseases, metabolic syndrome, and many other diseases of significant public health concern. The ideal response to initial challenges of the host is complete resolution of the acute inflammatory response, which is now recognized to be a biosynthetically active process governed by specialized pro-resolving mediators (SPM). These chemically distinct families include lipoxins, resolvins, protectins and maresins that are biosynthesized from essential fatty acids. The biosynthesis and complete stereochemical assignments of the major SPM are established, and new profiling procedures have recently been introduced to document the activation of these pathways in vivo with isolated cells and in human tissues. The active resolution phase leads to tissue regeneration, where we've recently identified new molecules that communicate during resolution of inflammation to activate tissue regeneration in model organisms. This review presents an update on the documentation of the roles of SPMs and the biosynthesis and structural elucidation of novel mediators that stimulate tissue regeneration, coined conjugates in tissue regeneration. The identification and actions of the three families, maresin conjugates in tissue regeneration (MCTR), protectin conjugates in tissue regeneration (PCTR), and resolvin conjugates in tissue regeneration (RCTR), are reviewed here. The identification, structural elucidation and the pathways and biosynthesis of these new mediators in tissue regeneration demonstrate the host capacity to protect from collateral tissue damage, stimulate clearance of bacteria and debris, and promote tissue regeneration via endogenous pathways and molecules in the resolution metabolome.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28802833      PMCID: PMC5832503          DOI: 10.1016/j.mam.2017.08.002

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  191 in total

1.  Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception.

Authors:  S Bang; S Yoo; T J Yang; H Cho; Y G Kim; S W Hwang
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 2.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

Review 3.  n-3 fatty acids in cardiovascular disease.

Authors:  Raffaele De Caterina
Journal:  N Engl J Med       Date:  2011-06-23       Impact factor: 91.245

4.  Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production.

Authors:  Anna Polus; Barbara Zapala; Urszula Razny; Anna Gielicz; Beata Kiec-Wilk; Malgorzata Malczewska-Malec; Marek Sanak; Caroline E Childs; Philip C Calder; Aldona Dembinska-Kiec
Journal:  Biochim Biophys Acta       Date:  2016-08-12

5.  Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.

Authors:  Min Wan; Catherine Godson; Patrick J Guiry; Birgitta Agerberth; Jesper Z Haeggström
Journal:  FASEB J       Date:  2011-02-09       Impact factor: 5.191

6.  Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.

Authors:  Justin T English; Paul C Norris; Robin R Hodges; Darlene A Dartt; Charles N Serhan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-01-19       Impact factor: 4.006

Review 7.  Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation.

Authors:  Takao Shimizu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

8.  Infection regulates pro-resolving mediators that lower antibiotic requirements.

Authors:  Nan Chiang; Gabrielle Fredman; Fredrik Bäckhed; Sungwhan F Oh; Thad Vickery; Birgitta A Schmidt; Charles N Serhan
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

Review 9.  Role of basic science in the development of new medicines: examples from the eicosanoid field.

Authors:  Bengt Samuelsson
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

10.  Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis.

Authors:  Shi Tang; Chenlin Gao; Yang Long; Wei Huang; Jiao Chen; Fang Fan; Chunxia Jiang; Yong Xu
Journal:  Mediators Inflamm       Date:  2017-01-15       Impact factor: 4.711

View more
  71 in total

Review 1.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.

Authors:  Charles N Serhan; Bruce D Levy
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 2.  Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases.

Authors:  Francisco J Schopfer; Dario A Vitturi; Diane K Jorkasky; Bruce A Freeman
Journal:  Nitric Oxide       Date:  2018-06-23       Impact factor: 4.427

Review 3.  Specialized pro-resolving mediator network: an update on production and actions.

Authors:  Nan Chiang; Charles N Serhan
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

4.  Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.

Authors:  Kaustubh Parashar; Fabian Schulte; Markus Hardt; Olga J Baker
Journal:  FASEB J       Date:  2020-04-11       Impact factor: 5.191

Review 5.  Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.

Authors:  Ganesh V Halade; Laurence M Black; Mahendra Kumar Verma
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

6.  New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses.

Authors:  Nan Chiang; Ian R Riley; Jesmond Dalli; Ana R Rodriguez; Bernd W Spur; Charles N Serhan
Journal:  FASEB J       Date:  2018-02-28       Impact factor: 5.191

7.  First total syntheses of the pro-resolving lipid mediators 7(S),13(R),20(S)-Resolvin T1 and 7(S),13(R)-Resolvin T4.

Authors:  Ana R Rodriguez; Bernd W Spur
Journal:  Tetrahedron Lett       Date:  2019-12-05       Impact factor: 2.415

Review 8.  Redox (phospho)lipidomics of signaling in inflammation and programmed cell death.

Authors:  Yulia Y Tyurina; Claudette M St Croix; Simon C Watkins; Alan M Watson; Michael W Epperly; Tamil S Anthonymuthu; Elena R Kisin; Irina I Vlasova; Olga Krysko; Dmitri V Krysko; Alexandr A Kapralov; Haider H Dar; Vladimir A Tyurin; Andrew A Amoscato; Elena N Popova; Sergey B Bolevich; Peter S Timashev; John A Kellum; Sally E Wenzel; Rama K Mallampalli; Joel S Greenberger; Hulya Bayir; Anna A Shvedova; Valerian E Kagan
Journal:  J Leukoc Biol       Date:  2019-05-09       Impact factor: 4.962

9.  First total synthesis of the pro-resolving lipid mediator 7(S),12(R),13(S)-Resolvin T2 and its 13(R)-epimer.

Authors:  Ana R Rodriguez; Bernd W Spur
Journal:  Tetrahedron Lett       Date:  2020-03-19       Impact factor: 2.415

10.  Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids.

Authors:  Charles N Serhan; Xavier de la Rosa; Charlotte C Jouvene
Journal:  J Immunol       Date:  2018-10-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.